ACH (Accendra Health, Inc.) Stock Analysis - Insider Trades

Accendra Health, Inc. (ACH) is a publicly traded the market company. As of May 21, 2026, ACH trades at $2.67 with a market cap of $209.84M and a P/E ratio of 0.00. ACH moved -4.64% today. Year to date, ACH is +34.85%; over the trailing twelve months it is flat. Its 52-week range spans $1.84 to $4.69. Analyst consensus is neutral with an average price target of $4.44. Rallies surfaces ACH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ACH stock inside the company?

Rallies tracks ACH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.

ACH Key Metrics

Key financial metrics for ACH
MetricValue
Price$2.67
Market Cap$209.84M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.12%
52-Week High$4.69
52-Week Low$1.84
Volume8
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ACH News

ACH Analyst Consensus

4 analysts cover ACH: 0 strong buy, 2 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $4.44.

Common questions about ACH

Who is trading ACH stock inside the company?
Rallies tracks ACH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
Does Rallies show Form 4 insider transactions for ACH?
Yes. Rallies tracks ACH insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ACH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACH. It does not provide personalized investment advice.
ACH

ACH